Alliancebernstein L.P. Adamas Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$280 Billion
Q4 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 13, 2020	SELL	N/A	-42,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	N/A	-7,000 Reduced 14.08%	42,700 $218,000
Q2 2019 Aug 14, 2019	BUY	N/A	1,700 Added 3.54%	49,700 $308,000
Q1 2019 May 14, 2019	SELL	N/A	-1,177,839 Reduced 96.08%	48,000 $341,000
Q4 2018 Feb 13, 2019	BUY	N/A	379,460 Added 44.83%	1,225,839 $10.5 Million
Q3 2018 Nov 08, 2018	BUY	N/A	129,763 Added 18.11%	846,379 $16.9 Million
Q2 2018 Aug 13, 2018	BUY	N/A	59,510 Added 9.06%	716,616 $18.5 Million
Q1 2018 May 14, 2018	SELL	N/A	-631 Reduced 0.1%	657,106 $15.7 Million
Q4 2017 Feb 13, 2018	BUY	N/A	77,303 Added 13.32%	657,737 $22.3 Million
Q3 2017 Nov 13, 2017	BUY	N/A	580,434	580,434 $12.3 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.